Alerts will be sent to your verified email
Verify Email
BROOKS
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Brooks Laboratories Limited focuses on critical care products including Beta Lactam, Cephalosporin, and General Dry powder Injectables. It provides a diverse product portfolio for multiple companies.
Brooks Laboratories major competitors are Alpa Lab, Krebs Biochem.&Inds, Balaxi Pharma., Panchsheel Organics, Coral Laboratories, Achyut Healthcare, Denis Chem Lab.
Market Cap of Brooks Laboratories is ₹147 Crs.
While the median market cap of its peers are ₹145 Crs.
Brooks Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Brooks Laboratories is 4.85 and is ranked 5 out of its 8 competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Dec | ||||||||||||||||||
| Investor Presentation | |||||||||||||||||||
| Conference Call | |||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
